Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma

Conclusion Pretreatment anemia, pretreatment CRP levels, and six-month posttreatment anemia are significantly associated with poor outcome, but were not proven to be of additional prognostic value to the current risk stratification index for DLBCL. Teaser This study aimed to determine the prognostic value of pretreatment anemia, pretreatment C-reactive protein (CRP) levels, and six-month posttreatment anemia in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Pretreatment anemia, elevated pretreatment CRP levels, and six-month posttreatment anemia were significantly associated with poor outcome, but were not of additional prognostic value to the current DLBCL risk stratification index.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research